News | Cath Lab | August 17, 2015

Global Interventional Cardiology Devices Market Worth $25.16 Billion by 2020

North American market driven by governmental support of new products, rising patient awareness

global interventional cardiology devices market, worth, Grand View Research, stents, catheters

August 17, 2015 — The global interventional cardiology devices market is expected to reach $25.16 billion by 2020, according to a new report by Grand View Research. Increasing prevalence of cardiovascular diseases coupled with adoption of minimally invasive surgeries is expected to boost the interventional cardiology device market over the forecast period. Unhealthy lifestyle habits such as high alcohol consumption, smoking and lack of physical exercise are triggering incidences of cardiovascular diseases. Furthermore, the number of congenital heart disease patients is on a constant rise and this acts as a growth driver for the market.

According to a report published by the Centers for Disease Control and Prevention (CDC) in 2011, congenital heart defects are the most common birth defects in the United States, affecting approximately 1 percent of the births every year. The treatment of cardiovascular disorders has changed dramatically due to the introduction of new drug therapies and devices such as guidewires and stents allowing the patient to live better quality and longer lives.

The advent of technologically advanced internal substitutes plays an integral role in this market and manufacturers focus on developing new products to curb problems associated with previous versions. For example, the evolution of stents began from bare metal stents and has now reached a completely new horizon in the form of disappearing stents (bio-absorbable stents). Stents accounted for over 70 percent market share primarily owing to high usage rates in 2013.

Catheters in sync with stents are expected to register steady growth to reach up to a market size of over $2.5 billion in 2020. The growth is primarily driven by the rising demand for minimally invasive medical procedures in the field of cardiovascular diseases. Faster patient recovery time and lesser procedure duration are the two most significant factors contributing towards the rising demand of these medical procedures.

The North American interventional cardiology device market in 2013 was valued at over $5.5 billion, owing to factors such as the presence of favorable government initiatives encouraging new product development, sophisticated healthcare infrastructure and increasing patient awareness levels, coupled with relatively higher healthcare expenditures in the region.

On the other hand, the Asia Pacific market is expected to reach over $6.4 billion by 2022, growing at a lucrative rate over the forecast period. The growth is attributed to the presence of large untapped opportunities, rising healthcare expenditure, cardiovascular disease incidence rate and disposable income levels.

Prominent players operating in this industry includes Cordis Corporation, Abbott Laboratories, Medtronic Inc, Terumo Medical Corp., B. Braun Melsungen AG and Boston Scientific.

For more information: www.grandviewresearch.com

Related Content

Screening for Critical Congenital Heart Disease at Birth Saves Lives
News | Congenital Heart| December 05, 2017
Infant deaths from critical congenital heart disease (CCHD) decreased more than 33 percent in eight states that...
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart| September 05, 2017
Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified...
AHA and ACC Publish New Data Dictionary for Ambulatory EHRs in Pediatric and Congenital Cardiology
News | Congenital Heart| July 19, 2017
July 19, 2017 — The American Heart Association (AHA) and the American College of Cardiology (ACC) recently published
New Multi-Center Research Effort to Focus on Early Life Origins of Heart Health
News | Congenital Heart| June 23, 2017
Heart health in children will be the focus of three closely synergistic research projects and an integrated...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
pediatric cardiomyopathy, management, clinical outcomes, NIH study, Circulation Heart Failure, Children's Hospital of Michigan
News | Congenital Heart| April 04, 2017
A multi-center study done in the United States and Canada may have global applicability for families with children...
Philips, Phoenix Children's Hospital, strategic partnership, congenital heart
News | Congenital Heart| March 07, 2017
Philips and Phoenix Children’s Hospital (Arizona) announced a long-term strategic partnership with a total value of up...
Jaheim Whigham, Lurie Children's Hospital of Chicago, Syncardia 50cc Total Artificial Heart, youngest patient

At 11 years old, Jaheim Whigham (center) is the youngest and smallest patient to receive the 50cc SynCardia temporary Total Artificial Heart. (Photo: Jan Terry, Ann & Robert H. Lurie Children's Hospital of Chicago)

News | Congenital Heart| January 31, 2017
To save the life of an 11-year-old boy, Ann & Robert H. Lurie Children’s Hospital of Chicago has become the first...
congenital heart disease, CHSD, Society of Thoracic Surgeons, public reporting, parent preferences
News | Congenital Heart| January 25, 2017
Survival statistics, surgeon-specific experience and complication rates are the types of information most wanted by...
extremely premature newborns, patent ductus arteriosus, PDA, hole in the heart, nonsurgical repair, catheter-based intervention
News | Congenital Heart| January 04, 2017
A new minimally invasive technique for repairing the most common cardiac birth defect in extremely premature newborns...
Overlay Init